Skip to main content

Table 1 Clinical profile and clotting factor concentrate exposure of HIV-Exposed/HIVseronegative hemophiliacs.

From: Evidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera

  

Hemophilia

 

Factor_concentrate exposure (1980–1985)

Patient #

Year of birth

Type

Severity*

Presence of inhibitor**

Type

Average Units/year

1

1972

B

<1%

No

PCC

55,000

2

1956

B

4%

No

PCC

<10,000

3

1966

A

<1%

Yes

PCC

27,000

4

1953

A

<1%

No

VIII

15,000

5

1977

B

<1%

No

PCC

29,000

6

1971

A

<1%

Yes

PCC

30,000

7

1931

A

<1%

No

VIII

11,000

8

1976

B

<1%

No

PCC

18,000

9

1964

B

<1%

No

PCC

24,000

10

1976

A

<1%

Yes

PCC

12,000

11

1957

A

<1%

No

VIII

29,000

12

1950

A

<1%

Yes

PCC

80,000

13

1969

B

2%

No

PCC

22,000

14

1959

A

<1%

No

VIII

10,000

15

1946

B

<1%

No

PCC

19,000

  1. * Normal factor VIII and Ix levels are 50–150%
  2. ** Inhibitor indicates the presence of a circulating antibody against the deficient factor; for patients with hemophilia A, an inhibitor often necessitates the use of PCC instead of factor VIII concentrates to control bleeding.